Other languages Evaxion Biotech A/S

Equities

EVAX

US29970R2040

Delayed Nasdaq Other stock markets 01:35:31 2024-05-08 pm EDT			5-day change	1st Jan Change
3.824 ^USD	-2.21%		-2.21%	-44.24%

May. 06	European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading	MT
May. 03	European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Set to Close Week Lower	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading	May. 06
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Set to Close Week Lower	May. 03
European Equities Traded in the US as American Depositary Receipts Rise Modestly Higher in Thursday Trading	May. 02
European Equities Traded in the US as American Depositary Receipts Trend Modestly Lower in Wednesday Trading	May. 01
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Monday Trading	Apr. 29
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.4%	Apr. 26
Evaxion Biotech A/S Elects Lars Staal Wegner as A New Board Member	Apr. 25
Evaxion Announces Phase 2 Clinical Trial Update	Apr. 17
European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading	Apr. 11
European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading	Apr. 09
European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading	Apr. 08
European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading, Close Out Week Lower	Apr. 05
European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading	Apr. 03
Sector Update: Health Care Stocks Slide Late Afternoon	Apr. 02
Sector Update: Health Care Stocks Slipping in Afternoon Trading	Apr. 02
Evaxion's EVX-B1 Vaccine Shows Promising Protection Against Staph Infections in Preclinical Studies; Shares Jump	Apr. 02
Evaxion and Undisclosed Collaborator Announce Encouraging Results for Evx-B1 Vaccine Antigens Against Staphylococcus Aureus Infection	Apr. 02
European Equities Traded in the US as American Depositary Receipts Slightly Higher Thursday	Mar. 28
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Wednesday Trading	Mar. 27
Evaxion Biotech A/S Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 26

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Evaxion Biotech A/S

Equities

EVAX

US29970R2040

Other languages

Filters